Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1714864

registered interest
date	30/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Streptococcus: Babies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of making Group B Strep a notifiable disease on the (a) prevention and (b) treatment of this infection in newborns.
tabling member constituency	Stroud
tabling member printed	Siobhan Baillie
uin	24343
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>Notifiable diseases, listed under schedule 1 of the Health Protection (Notification) Regulations 2010, are kept under review by the Department and the UK Health Security Agency (UKHSA). The Government published a public consultation between 12 July and 15 November 2023, seeking views on proposed amendments to the regulations, including adding diseases to schedule 1 to make them notifiable.</p><p>Adding Group B Streptococcal (GBS) Infection to schedule 1 was not included in the consultation proposals, but a small number of respondents suggested it could be suitable for inclusion. A summary of responses to the consultation has been published. The Department and the UKHSA are considering the consultation responses, and confirmation of any changes to the regulations will be published in due course.</p><p>To increase awareness and understanding of GBS, NHS England published a revised Core Competency Framework in May 2023, which covers the mandated training for all maternity services, which now includes GBS. Undertaking this training will enable midwives and doctors to be better informed when speaking to families about the risk of GBS in labour. The Core Competency Framework is incentivised through the maternity incentive scheme administrated by NHS Resolution.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 07/05/2024 16:41:43 answering member 4492 label Biography information for Maria Caulfield
tabling member	4847 label Biography information for Siobhan Baillie

1714865

registered interest
date	30/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Streptococcus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what systems her Department has in place to (a) track and (b) report cases of Group B Strep infection; and if she will make an assessment of the potential impact of making Group B Strep a notifiable disease on those systems.
tabling member constituency	Stroud
tabling member printed	Siobhan Baillie
uin	24344
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>National surveillance systems, established and managed by the UK Health Security Agency (UKHSA), are used to monitor trends, characteristics, and outcomes of Group B Streptococcus (GBS) infection, vital to prevention efforts. These include the reporting of cases diagnosed in local microbiology laboratories, and the submission of clinical isolates to the national reference laboratory. Analyses based on this surveillance is published in annual reports.</p><p>The UKHSA has jointly co-ordinated periods of enhanced surveillance with academic and public health collaborators, allowing greater understanding of risk factors and outcomes of infection, vital in identifying opportunities for prevention. Data generated through laboratory surveillance is utilised to assess the impact of prevention efforts.</p><p>The list of notifiable diseases is kept under review by the Department, with UKHSA involvement. Should GBS be added to the list of notifiable diseases, the means to assess the impact of this change on surveillance data will be considered.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 07/05/2024 16:37:36 answering member 4492 label Biography information for Maria Caulfield
tabling member	4847 label Biography information for Siobhan Baillie

1700999

registered interest
date	15/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sodium Valproate: Compensation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what her Department's timescales are for responding to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024.
tabling member constituency	Stroud
tabling member printed	Siobhan Baillie
uin	21866
answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 21867 question first answered 19/04/2024 13:23:37 answering member 4492 label Biography information for Maria Caulfield
tabling member	4847 label Biography information for Siobhan Baillie

1701000

registered interest
date	15/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgical Mesh Implants: Compensation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024, if she will ensure that people impacted by bowel mesh are eligible for financial redress.
tabling member constituency	Stroud
tabling member printed	Siobhan Baillie
uin	21867
answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 21866 question first answered 19/04/2024 13:23:37 answering member 4492 label Biography information for Maria Caulfield
tabling member	4847 label Biography information for Siobhan Baillie